“The decision to convert to FORE-SIGHT Cerebral Oximetry was based on evaluating what was best for our patients, said Dr Mike Hartley, Consultant Cardiothoracic Anaesthetist at the Lancashire Cardiac Centre. It is vitally important for us to incorporate technologies that will help us to improve patient care. With FORE-SIGHT, we believe that we will be able to better detect and resolve problems with cerebral perfusion before they can negatively impact patients.”
CASMED’s president and chief executive officer, Andrew E. Kersey, stated: “We are delighted that, after evaluating all available technologies, the Lancashire Cardiac Centre chose FORE-SIGHT as a standard-of-care in their facility to non-invasively measure brain oxygen saturation during critical procedures. FORE-SIGHT’s accuracy and performance will allow the Lancashire Cardiac Centre to better monitor, manage and treat patients at risk for decreased cerebral oxygen saturation.”
